Clinical Trial of CD19 CAR-T Cell Therapy with non-virus Vector System

被引：0
|
作者：
Takahashi, Yoshiyuki [1 ]
机构：
[1] Nagoya Univ, Dept Pediat, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-1
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [41] Development of a translatable CD19 CAR-T platform for drug discovery
    Kelsey, Lauren
    Self-Fordham, Jezrom
    Oswald, Eva
    Aylott, Ilona
    Rocca, Daniel
    Nunan, Robert
    Harris, David
    Schueler, Julia
    Jenkinson, Rhiannon
    CANCER RESEARCH, 2022, 82 (12)
  • [42] Two years later: CD19 CAR-T going the distance
    Darnell, Eli P.
    Frigault, Matthew J.
    BLOOD, 2024, 143 (05) : 379 - 380
  • [43] Challenge of cryopreservation for gmp grade CD19 CAR-T cells
    Gong, Wenjie
    Wang, Lei
    Wang, Sanmei
    Neuber, Brigitte
    Sellner, Leopold
    Schubert, Maria-Luisa
    Hueckelhoven-Krauss, Angela
    Kunz, Alexander
    Gern, Ulrike
    Michels, Birgit
    Hinkelbein, Mandy
    Mechler, Stefanie
    Richter, Petra
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BONE MARROW TRANSPLANTATION, 2019, 54 : 186 - 187
  • [44] Detail Analysis of Non-Specific Activation of CD19 CAR-T Cells Caused by CAR Design
    Okamoto, Sachiko
    Amaishi, Yasunori
    Pei, Zheng
    Mineno, Junichi
    MOLECULAR THERAPY, 2015, 23 : S84 - S85
  • [45] CD19 CAR-T Cell Therapy at the LMU Munich from 2019 to 2021: Increasing Therapy Safety over the Years
    Bucklein, V
    Blumenberg, V
    Frolich, L.
    Ackermann, J.
    Schmidt, C.
    Hildebrand, F.
    Rejeski, K.
    Winkelmann, M.
    Schoberl, F.
    Kunz, W.
    Von Baumgarten, L.
    Humpe, A.
    Von Bergwelt, M.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 125 - 125
  • [46] Assessing impacts of tumor burden and CAR-T cell dosage on the toxicity and efficacy profile of CD19 CAR-T therapy in a PBMC-humanized mouse model
    Lee, Won
    Rose, Destanie
    Keck, James G.
    Yang, Jiwon
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Long-Term Safety and Efficacy of CD19 Humanized Selective CAR-T Therapy in B-ALL Patients Who Have Previously Received Murine-Based CD19 CAR-T Therapy
    Zhao, Yu
    Zhang, Jianping
    Yang, Junfang
    Wu, Huantong
    Chen, Yao
    Li, Nannan
    Liu, Zhongfeng
    Wang, Xuan
    Liu, Weihua
    Zhang, Guangji
    Zhou, Bin-Bing Stephen
    Lu, Peihua
    Chen, Zhiguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
    Kinoshita, Hannah
    Bollard, Catherine M.
    Toner, Keri
    SEMINARS IN HEMATOLOGY, 2023, 60 (05) : 329 - 337
  • [49] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [50] CD19 CAR T cell therapy effective for systemic lupus erythematosus
    Gelfand, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (01) : 4 - 4
12345